Nanotechnology and nanomedicine: going small means aiming big.

Nanotechnology is an emerging branch of science for designing tools and devices of size 1 to 100 nm with specific function at the cellular, atomic and molecular levels. The concept of employing nanotechnology in biomedical research and clinical practice is best known as nanomedicine. Nanomedicine is an upcoming field that could potentially make a major impact to human health. Nanomaterials are increasingly used in diagnostics, imaging and targeted drug delivery. Nanotechnology will assist the integration of diagnostics/imaging with therapeutics and facilitates the development of personalized medicine, i.e. prescription of specific medications best suited for an individual. This review provides an integrated overview of application of nanotechnology based molecular diagnostics and drug delivery in the development of nanomedicine and ultimately personalized medicine. Finally, we identify critical gaps in our knowledge of nanoparticle toxicity and how these gaps need to be evaluated to enable nanotechnology to transit safely from bench to bedside.

[1]  Harvey R Herschman,et al.  Molecular Imaging: Looking at Problems, Seeing Solutions , 2003, Science.

[2]  R. Feynman.  There’s plenty of room at the bottom , 1992, Journal of Microelectromechanical Systems.

[3]  Tuan Vo-Dinh,et al.  Nanotechnology in Biology and Medicine : Methods, Devices, and Applications , 2007 .

[4]  C. Plank.  Nanomedicine: Silence the target. , 2009, Nature nanotechnology.

[5]  Personalized clinical laboratory diagnostics. , 2009, Advances in clinical chemistry.

[6]  S. Caruthers,et al.  19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Samuel A Wickline,et al.  Nanotechnology for molecular imaging and targeted therapy. , 2003, Circulation.

[8]  K. Jain.  Role of nanobiotechnology in the development of personalized medicine. , 2009, Nanomedicine.

[9]  Mauro Ferrari,et al.  The Molecular Analysis of Breast Cancer Utilizing Targeted Nanoparticle Based Ultrasound Contrast Agents , 2005, Technology in cancer research & treatment.

[10]  Himanshu P. Shukla,et al.  Molecular Imaging of Human Thrombus with Computed Tomography , 2005 .

[11]  R R Edelman,et al.  Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). , 1995, AJR. American journal of roentgenology.

[12]  Thomas J. Webster,et al.  The Role of Nanomedicine in Growing Tissues , 2009, Annals of Biomedical Engineering.

[13]  Xiaoyuan Chen,et al.  Applications for site-directed molecular imaging agents coupled with drug delivery potential , 2009, Expert opinion on drug delivery.

[14]  B. Nowack,et al.  Occurrence, behavior and effects of nanoparticles in the environment. , 2007, Environmental pollution.

[15]  Bing Xu,et al.  Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. , 2009, Accounts of chemical research.

[16]  H. Barroca.  Fine needle biopsy and genetics, two allied weapons in the diagnosis, prognosis, and target therapeutics of solid pediatric tumors , 2008, Diagnostic cytopathology.

[17]  Hisataka Kobayashi,et al.  Nano-sized MRI contrast agents with dendrimer cores. , 2005, Advanced drug delivery reviews.

[18]  S. Darling,et al.  A materials chemistry perspective on nanomagnetism , 2005 .

[19]  D. Luo.  Nanotechnology and DNA Delivery , 2005 .

[20]  Samuel A Wickline,et al.  Targeted ultrasonic contrast agents for molecular imaging and therapy. , 2001, Current problems in cardiology.